Juan González Del Castillo, Begoña Espinosa, Nayra Cabrera, María Teresa Sánchez Moreno, Plácido Mayán, Alexis Rebollo, Julio Javier Gamazo, Hugo Martinez Faya, María Esperanza Puga Montalvo, Isidro Baez, Rocío de Paz, Javier Cabañas, Jesús Álvarez Manzanares, Òscar Miró
{"title":"三种不同干预措施的影响,这些干预措施旨在改善急诊部门艾滋病毒检测选择有针对性战略的执行情况。","authors":"Juan González Del Castillo, Begoña Espinosa, Nayra Cabrera, María Teresa Sánchez Moreno, Plácido Mayán, Alexis Rebollo, Julio Javier Gamazo, Hugo Martinez Faya, María Esperanza Puga Montalvo, Isidro Baez, Rocío de Paz, Javier Cabañas, Jesús Álvarez Manzanares, Òscar Miró","doi":"10.1111/hiv.70074","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Undiagnosed HIV infection remains the main driver of new HIV cases in Western countries. Emergency Departments (EDs) offer a key opportunity for detection. In 2020, Spanish emergency and infectious diseases societies recommended an opt-in strategy for targeted conditions for HIV testing in EDs. This study evaluates the efficacy of three strategies for targeted HIV testing.</p><p><strong>Methods: </strong>Twelve Spanish EDs, selected based on predefined structural criteria, assessed HIV testing from April to June 2024. Hospitals applied: no strategy (control, three EDs), an educational programme (strategy A, three EDs), strategy A plus preconfigured electronic orders (strategy B, three EDs) or strategy B plus electronic alerts in medical records (strategy C, three EDs). The impact on HIV testing was measured overall and by targeted condition, using absolute differences with 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Of the 612 909 ED visits, 210 039 occurred in control hospitals (1232 patients [0.59%] had targeted conditions), 172 806 in hospitals applying strategy A (1497 [0.87%]), 132 835 in strategy B hospitals (1761 [1.33%]) and 97 229 in hospitals applying strategy C (1269 [1.31%]). Testing rates were 0.16%, 0.38%, 1.17% and 2.16% in the control, and strategy A, B and C EDs., respectively. Among patients with targeted conditions, testing reached 13.1%, 22.9%, 30.7% and 78.1%. Compared to no strategy, testing increased by 0.22% (95% CI = 0.18-0.25) with strategy A, 0.79% (95% CI = 0.73-0.86) with B, and 0.98% (95% CI = 0.88-1.09) with C. In targeted conditions, testing rose by 9.8%, 7.8% and 47.5% for strategies A, B and C, respectively. All strategies improved testing in sexually transmitted infections (STI), meningitis/neurological syndromes and community-acquired pneumonia (CAP); strategy C also increased testing in herpes zoster (HZ) and post-exposure prophylaxis.</p><p><strong>Conclusion: </strong>All the strategies evaluated enhanced targeted HIV testing, especially strategy C (electronic alerts), which was associated with the highest testing rates observed, particularly in STI, CAP and HZ.</p>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of three different interventions designed to improve the implementation of an opt-in targeted strategy of HIV testing in emergency departments.\",\"authors\":\"Juan González Del Castillo, Begoña Espinosa, Nayra Cabrera, María Teresa Sánchez Moreno, Plácido Mayán, Alexis Rebollo, Julio Javier Gamazo, Hugo Martinez Faya, María Esperanza Puga Montalvo, Isidro Baez, Rocío de Paz, Javier Cabañas, Jesús Álvarez Manzanares, Òscar Miró\",\"doi\":\"10.1111/hiv.70074\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Undiagnosed HIV infection remains the main driver of new HIV cases in Western countries. Emergency Departments (EDs) offer a key opportunity for detection. In 2020, Spanish emergency and infectious diseases societies recommended an opt-in strategy for targeted conditions for HIV testing in EDs. This study evaluates the efficacy of three strategies for targeted HIV testing.</p><p><strong>Methods: </strong>Twelve Spanish EDs, selected based on predefined structural criteria, assessed HIV testing from April to June 2024. Hospitals applied: no strategy (control, three EDs), an educational programme (strategy A, three EDs), strategy A plus preconfigured electronic orders (strategy B, three EDs) or strategy B plus electronic alerts in medical records (strategy C, three EDs). The impact on HIV testing was measured overall and by targeted condition, using absolute differences with 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Of the 612 909 ED visits, 210 039 occurred in control hospitals (1232 patients [0.59%] had targeted conditions), 172 806 in hospitals applying strategy A (1497 [0.87%]), 132 835 in strategy B hospitals (1761 [1.33%]) and 97 229 in hospitals applying strategy C (1269 [1.31%]). Testing rates were 0.16%, 0.38%, 1.17% and 2.16% in the control, and strategy A, B and C EDs., respectively. Among patients with targeted conditions, testing reached 13.1%, 22.9%, 30.7% and 78.1%. Compared to no strategy, testing increased by 0.22% (95% CI = 0.18-0.25) with strategy A, 0.79% (95% CI = 0.73-0.86) with B, and 0.98% (95% CI = 0.88-1.09) with C. In targeted conditions, testing rose by 9.8%, 7.8% and 47.5% for strategies A, B and C, respectively. All strategies improved testing in sexually transmitted infections (STI), meningitis/neurological syndromes and community-acquired pneumonia (CAP); strategy C also increased testing in herpes zoster (HZ) and post-exposure prophylaxis.</p><p><strong>Conclusion: </strong>All the strategies evaluated enhanced targeted HIV testing, especially strategy C (electronic alerts), which was associated with the highest testing rates observed, particularly in STI, CAP and HZ.</p>\",\"PeriodicalId\":13176,\"journal\":{\"name\":\"HIV Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-07-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/hiv.70074\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/hiv.70074","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
目的:未确诊的艾滋病毒感染仍然是西方国家新发艾滋病毒病例的主要驱动因素。急诊科(EDs)提供了检测的关键机会。2020年,西班牙急诊和传染病学会建议在急诊科开展有针对性的艾滋病毒检测条件选择加入战略。本研究评估了三种靶向HIV检测策略的有效性。方法:根据预定义的结构标准选择12名西班牙ed,于2024年4月至6月进行HIV检测。医院采用:无策略(控制,三个急诊室),教育方案(策略A,三个急诊室),策略A加上预先配置的电子订单(策略B,三个急诊室)或策略B加上医疗记录中的电子警报(策略C,三个急诊室)。对艾滋病毒检测的影响是通过总体和目标条件来衡量的,使用95%置信区间(ci)的绝对差异。结果:612 909例急诊科就诊中,对照医院为210 039例(符合目标条件的1232例(0.59%)),A策略医院为172 806例(1497例(0.87%)),B策略医院为132 835例(1761例(1.33%)),C策略医院为97 229例(1269例(1.31%))。对照组和A、B、C策略组的阳性率分别为0.16%、0.38%、1.17%和2.16%。,分别。在有针对性的患者中,检测率分别为13.1%、22.9%、30.7%和78.1%。与无策略相比,策略A的测试增加了0.22% (95% CI = 0.18-0.25),策略B的测试增加了0.79% (95% CI = 0.73-0.86),策略C的测试增加了0.98% (95% CI = 0.88-1.09)。在目标条件下,策略A、B和C的测试分别增加了9.8%、7.8%和47.5%。所有战略都改进了性传播感染(STI)、脑膜炎/神经综合征和社区获得性肺炎(CAP)的检测;策略C还增加了带状疱疹(HZ)和接触后预防的检测。结论:所有评估的策略都增强了针对性的HIV检测,特别是策略C(电子警报),其检测率最高,特别是在STI, CAP和HZ中。
Impact of three different interventions designed to improve the implementation of an opt-in targeted strategy of HIV testing in emergency departments.
Objectives: Undiagnosed HIV infection remains the main driver of new HIV cases in Western countries. Emergency Departments (EDs) offer a key opportunity for detection. In 2020, Spanish emergency and infectious diseases societies recommended an opt-in strategy for targeted conditions for HIV testing in EDs. This study evaluates the efficacy of three strategies for targeted HIV testing.
Methods: Twelve Spanish EDs, selected based on predefined structural criteria, assessed HIV testing from April to June 2024. Hospitals applied: no strategy (control, three EDs), an educational programme (strategy A, three EDs), strategy A plus preconfigured electronic orders (strategy B, three EDs) or strategy B plus electronic alerts in medical records (strategy C, three EDs). The impact on HIV testing was measured overall and by targeted condition, using absolute differences with 95% confidence intervals (CIs).
Results: Of the 612 909 ED visits, 210 039 occurred in control hospitals (1232 patients [0.59%] had targeted conditions), 172 806 in hospitals applying strategy A (1497 [0.87%]), 132 835 in strategy B hospitals (1761 [1.33%]) and 97 229 in hospitals applying strategy C (1269 [1.31%]). Testing rates were 0.16%, 0.38%, 1.17% and 2.16% in the control, and strategy A, B and C EDs., respectively. Among patients with targeted conditions, testing reached 13.1%, 22.9%, 30.7% and 78.1%. Compared to no strategy, testing increased by 0.22% (95% CI = 0.18-0.25) with strategy A, 0.79% (95% CI = 0.73-0.86) with B, and 0.98% (95% CI = 0.88-1.09) with C. In targeted conditions, testing rose by 9.8%, 7.8% and 47.5% for strategies A, B and C, respectively. All strategies improved testing in sexually transmitted infections (STI), meningitis/neurological syndromes and community-acquired pneumonia (CAP); strategy C also increased testing in herpes zoster (HZ) and post-exposure prophylaxis.
Conclusion: All the strategies evaluated enhanced targeted HIV testing, especially strategy C (electronic alerts), which was associated with the highest testing rates observed, particularly in STI, CAP and HZ.
期刊介绍:
HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.